Holoprosencephaly
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
A missense mutation c.686C>T was found in the gene SIX3 of one patient, which did not differ from the accepted 20% of known HPE gene mutations among all HPE cases.
|
17584896 |
2007 |
Holoprosencephaly
|
0.700 |
Biomarker
|
disease |
BEFREE |
Two families showed inherited deletions that contain SIX3 and were incompletely penetrant for HPE.
|
28670735 |
2018 |
Holoprosencephaly
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Mutations in SIX3 result in more severe HPE than in other cases of non-chromosomal, non-syndromic HPE.
|
19346217 |
2009 |
Schizencephaly
|
0.610 |
GeneticVariation
|
disease |
BEFREE |
Heterozygous mutations in SIX3 and SHH are associated with schizencephaly and further expand the clinical spectrum of holoprosencephaly.
|
20157829 |
2010 |
Panhypopituitarism
|
0.110 |
Biomarker
|
disease |
BEFREE |
The entire coding region of the TGIF, SHH, and SIX3 genes was sequenced in patients with combined pituitary hormone deficiency associated with either PSIS or IPH and in healthy controls.
|
23476075 |
2013 |
Cyclocephaly
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
We report a new HPE family, presenting a wide spectrum of clinical features, ranging from cyclopia to hypotelorism, in which a mutation was found for the first time in the SIX domain of SIX3: a GG insertion creates a frameshift leading to a nonsense mutation downstream in the homeodomain region.
|
11039582 |
2000 |
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
We studied two genes, Sonic Hedgehog (SHH) and SIX3, in which mutations have been reported in patients showing SMMCI as part of the HPE spectrum.
|
11471164 |
2001 |
Carcinogenesis
|
0.050 |
Biomarker
|
phenotype |
BEFREE |
Little is known about the role of SIX3 in human tumorigenesis.
|
23977152 |
2013 |
Carcinogenesis
|
0.050 |
Biomarker
|
phenotype |
BEFREE |
However, studies on the function of SIX3 in human tumorigenesis remain rare.
|
30672777 |
2019 |
Carcinogenesis
|
0.050 |
Biomarker
|
phenotype |
BEFREE |
However, little is known about the role of Six3 in human tumorigenesis.
|
28643150 |
2017 |
Carcinogenesis
|
0.050 |
Biomarker
|
phenotype |
BEFREE |
We demonstrate that the SIX3/LSD1/NuRD(MTA3) complex inhibits carcinogenesis in breast cancer cells and suppresses metastasis in breast cancer.
|
29463994 |
2018 |
Carcinogenesis
|
0.050 |
AlteredExpression
|
phenotype |
BEFREE |
Importantly, interactions between AURKA and AURKB stabilize and protect AURKA/B from degradation, and overexpression of SIX3 does not affect these interactions; SIX3 also acts as a tumor suppressor, and it increases p53 activity and expression at the post-translational level by the negative regulation of AURKA or AURKB, reduces the events of numerical centrosomal aberrations and misaligned chromosomes, and significantly inhibits the proliferation, invasion, and tumorigenesis of astrocytoma in vitro and in vivo.
|
28595628 |
2017 |
Neoplasm Metastasis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
We demonstrate that the SIX3/LSD1/NuRD(MTA3) complex inhibits carcinogenesis in breast cancer cells and suppresses metastasis in breast cancer.
|
29463994 |
2018 |
Neoplasm Metastasis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
A novel long noncoding RNA lncWDR26 suppresses the growth and metastasis of hepatocellular carcinoma cells through interaction with SIX3.
|
29736313 |
2018 |
Neoplasm Metastasis
|
0.030 |
GeneticVariation
|
phenotype |
BEFREE |
Restoration of SIX3 in lung cancer cells lacking endogenous SIX3 suppressed cell proliferation and migration, and downregulated a number of genes involved in proliferation and metastasis such as S100P, TGFB3, GINS3 and BAG1.
|
23977152 |
2013 |
Congenital Abnormality
|
0.020 |
Biomarker
|
group |
BEFREE |
Using samples from a population-based birth defects registry in California, we performed a mutational analysis of the known HPE genes Sonic Hedgehog (SHH), ZIC2, and SIX3, in addition to two HPE candidate genes, TG-interacting factor (TGIF), and Patched (PTC), on a group of sporadic HPE patients.
|
10710230 |
2000 |
Congenital Abnormality
|
0.020 |
GeneticVariation
|
group |
BEFREE |
We therefore considered holoprosencephaly (HPE)-associated genes as potential SCH candidates and report for the first time heterozygous mutations in SIX3 and SHH in a total of three unrelated patients and one fetus with SCH; one of them without obvious associated malformations of midline forebrain structures.
|
20157829 |
2010 |
Malignant neoplasm of breast
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
However, high SIX3 mRNA level was a protective factor for OS and RFS of basal-like breast cancer patients.Our study suggested that members of SIX family played distinct roles in breast cancer.
|
27399099 |
2016 |
Malignant neoplasm of breast
|
0.020 |
Biomarker
|
disease |
BEFREE |
We demonstrate that the SIX3/LSD1/NuRD(MTA3) complex inhibits carcinogenesis in breast cancer cells and suppresses metastasis in breast cancer.
|
29463994 |
2018 |
Chondrosarcoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas.
|
12543801 |
2003 |
Chondrosarcoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Coexpression of NOR1 and SIX3 proteins in extraskeletal myxoid chondrosarcomas without detectable NR4A3 fusion genes.
|
15262426 |
2004 |
Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
Considering the highly specific expression pattern of Six3, our finding that it is expressed in EMC suggests that it plays a pivotal role in the development of these tumors.
|
12543801 |
2003 |
Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
Importantly, interactions between AURKA and AURKB stabilize and protect AURKA/B from degradation, and overexpression of SIX3 does not affect these interactions; SIX3 also acts as a tumor suppressor, and it increases p53 activity and expression at the post-translational level by the negative regulation of AURKA or AURKB, reduces the events of numerical centrosomal aberrations and misaligned chromosomes, and significantly inhibits the proliferation, invasion, and tumorigenesis of astrocytoma in vitro and in vivo.
|
28595628 |
2017 |
Breast Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
However, high SIX3 mRNA level was a protective factor for OS and RFS of basal-like breast cancer patients.Our study suggested that members of SIX family played distinct roles in breast cancer.
|
27399099 |
2016 |
Breast Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
We demonstrate that the SIX3/LSD1/NuRD(MTA3) complex inhibits carcinogenesis in breast cancer cells and suppresses metastasis in breast cancer.
|
29463994 |
2018 |